The strategic development places the Ian Read as its chairman and opens up the CEO post which could be filled at a later date. Under Read’s steady stewardship, Pfizer Inc’s stock has gone up by 160% since December 2010. Pfizer… Read More ›
scrutiny
Australia’s Royal Commission begins inquiry alleged wrong-doings in the country’s financial sector
Allegations of widespread wrong-doings have plagued Australia’s finance sector since many years, adding pressure on the industry to undergo a thorough root-and branch reform. On Monday, the head of the government-backed inquiry which is delving into Australia’s finance sector to… Read More ›
Investors increasingly gravitating towards crypto-currencies
Although the issuance of initial coin offerings (ICO) have under regulatory scrutiny in the U.S, investors are expertly straddling borders with ease and are flocking to offshore destinations to raise millions in a matter of minutes. Interestingly, investors who are… Read More ›
Northrop Grumman’s acquisition of Orbital ATK Inc will exceed $7.7 billion
The deal is likely to be finalized on Monday, however, it could draw scrutiny from the Pentagon given the vertical integration related issues with weapon systems developed by Northrop Grumman and Orbital ATK. As per a source familiar with the… Read More ›
Barclays exits from trading in energy
Barclays exit isn’t surprising since many large investment banks have also minimized their profile in the energy trade following the 2008 financial crisis. While merchant traders have sought to fill its shoes, given their aversion to the futures market and… Read More ›
manageria.biz 